The Scottish health targets were established in 1991 in Health Education in Scotland-A National Policy Statement (SHHD, 1991) and reiterated in Scotland's Health-A Challenge to Us All (SHHD, 1992) . Among targets pertaining to the major causes of morbidity and mortality in the Scottish population was one directed specifically towards cancer: 'to reduce mortality from cancers in the under-65s by 15% between 1986 and 2000', that is, a reduction from 104 deaths per 100 000 to 88 deaths per 100 000 by the year 2000.
Since the last century information on cause of death has been recorded routinely by the Registrar General for Scotland and used to monitor trends in mortality from cancer. However, to assess the burden of disease it is necessary to be able to measure cases newly diagnosed in the population. Scotland is fortunate in that it is one of the few countries in the world with long-standing, national, population-based cancer registration. The Scottish National Cancer Registration Scheme aims to collect information on all incident cases of cancer in Scotland and has a database extending back to 1958. The availability of these long series of data provides an opportunity to estimate cancer incidence and mortality in future years. The purpose of this paper is to facilitate the assessment of progress towards attaining the Scottish Cancer Target by describing trends in incidence of, and mortality from, the common cancers over recent decades and presenting projected numbers of cases and deaths in the year 2000.
Data and methods
Registrations of cancer in the period 1968-92 were extracted from the national cancer database held by the Information & Statistics Division of the National Health Service in Scotland. Non-melanoma skin cancer (ICD-9 173) registrations were excluded as they are unlikely to be complete. With the permission of the General Register Office (Scotland), individual mortality records for 1968-92 with cancer recorded as the primary cause of death were extracted from computerised death listings.
A statistical model based on birth cohort, age and time period (Robertson and Boyle, 1986 ) was used to estimate the projected number of cancer registrations and deaths in Scotland in the year 2000. This method partially addresses the problem of overlapping birth cohorts by using individual cancer registration and mortality records to assign each individual to a unique cohort. Records were tabulated by period of diagnosis (or death) (1968-72, 1973 -77,..., 1988-92) , age at diagnosis (or death) (25-29, 30-34,. 80-84) and birth cohort (1883-87, 1888-92, ... , 1963-67) . For each cancer site included in the analysis, a log-linear model was fitted in GLIM (NAG, 1985) , with adjustment for extra-Poisson variation where necessary (Breslow, 1984) , to generate estimates of age, time period and birth cohort effects for registration and mortality data separately. The age effects represent differing risks associated with different age groups and may reflect cumulative exposure to cancer causing agents; the time period effects describe changes in rates occurring in all age groups simultaneously and may reflect, for example, increasing completeness of registration or the introduction of a new diagnostic technique; the birth cohort effects represent changes in rates in successive generations and may reflect differences in lifestyle or cultural habits such as reproductive practices or tobacco or alcohol consumption. Only those sites of cancer for which at least 200 cases were diagnosed in the age group 0-64 years in 1986 were included in these analyses. Males and females were considered separately. The individual cancers analysed were stomach (ICD-9 151), large bowel (ICD-9 153 + 154), lung (ICD-9 162), and bladder (ICD-9 188) in males and large bowel (ICD-9 153 + 154), lung (ICD-9 162), breast (ICD-9 174), cervix uteri (ICD-9 180) and ovary (ICD-9 183) in females. All malignant neoplasms models would continue in future periods. Estimates of age and birth cohort specific incidence and mortality rates from the fitted models were applied to population projections (Registrar General, 1993) to produce projected numbers of cases and deaths in the 0-64 age group. Percentage changes between the model estimates for 1986 and 2000 were calculated and applied to the actual 1986 registrations and deaths to obtain projected numbers in the year 2000. The results are presented in two sections. The first section concerns cancer in Scotland in the baseline year 1986. Numbers and percentages of the most common cancers in the under 65 population are presented. Five year relative survival rates were calculated as described by Black and coworkers (1993) for patients aged under 65 and diagnosed in two periods, 1968-72 and 1983-87 . Incidence and mortality rates for all malignant neoplasms in the under-65s in 1986, directly standardised with respect to the world population (Segi, 1960) , were obtained from the EUROCIM package (European Network of Cancer Registries, 1995) for Scotland and selected European cancer registries. The second section examines time trends in incidence and mortality and presents the projected numbers of registrations and deaths in the year 2000. Both crude and age-standardised rates are used depending on circumstances. To facilitate comparison with the Scottish Cancer Target, which is expressed in terms of unadjusted rates, crude incidence and mortality rates for individual cancer sites in 1986 and 1992 are shown. To permit assessment of long-term time trends in incidence and mortality, age-standardised rates (to the world population) for the period 1960-1992 were derived from Black et al. (1995) . These data are presented for all malignant neoplasms combined as well as for individual cancer sites.
Results
Cancer in Scotland in the baseline year 1986 Incidence In 1986, 10 795 males and 11 109 females of all ages were registered with cancer (non-melanoma skin cancer excluded) in Scotland. Of this total, 38% (8313) of cases occurred in those aged under 65 years, 56% (12 190) in the 65 to 84 age group and the remaining 6% (1401) in those aged 85 and older. The proportion of cancers presenting before 65 years in females (40%: 4452 registrations) was greater than that in males (36%: 3861) due, in the main, to cancer of the reproductive system in females.
The numbers and percentages of registrations for the most frequent cancers in persons under 65 years of age in 1986 are shown in Table I . In males, cancer of the lung accounted for the greatest proportion of registrations (28%), followed by cancers of the large bowel (11%) and bladder (7%). In females, 31 % of registrations were due to breast malignancies with a further 14% due to cancers of the cervix and ovary. Cancers of the lung and large bowel were also common (12% and 9% respectively).
Mortality Almost a third (4539) $ was 33% for males and 49% for females (Table II) . With the exception of lung cancer, survival from most common cancers improved between 1968-72 and 1983-87 (Table II) .
International comparisons Table III v 1960 1964 1968 1972 1976 1980 1984 1988 1992 Year of diagnosis/year of death aExcludes non-melanoma skin cancer (ICD-9 173).
In 1986 the crude incidence rates of all cancers in those under 65 were 176 per 100 000 in males and 204 per 100 000 in females (Figure 2 ). The rate for males was little changed by 1992, whereas incidence in women had risen by 11%. Mortality in 1986 was 107 and 101 per 100 000 for males and females respectively (Figure 3 ). By 1992 this had fallen by 8% in males and 3% in females.
In comparison with the baseline year, 1986, the number of cancers diagnosed in those under 65 years in Scotland in 2000 is forecast to fall by 6% to 3641 in males and increase marginally (0.2%) to 4461 in females (Table IV) . Substantial decreases in deaths are projected with the total in males falling by 17%, from 2341 to 1943, and in females by 25%, from 2198 to 1649 (Table V) Data for all malignant neoplasms are difficult to interpret and may conceal divergent patterns for specific cancers. In men, substantial falls in the numbers of cases of, and deaths from, stomach and lung cancer can be expected. In women under 65, a reduction in the number of lung neoplasms is also anticipated. This is discussed more fully below. Women are also expected to experience increases in the numbers of diagnosed tumours of the cervix and, to a lesser extent, breast. In contrast, mortality is predicted to remain unchanged for cervical cancer and to decline for breast cancer. Organised screening exists for these cancers (Warner et al., 1993; Strong, 1986) and is expected to influence trends in both incidence and mortality greatly.
The specific cancer sites examined in this paper account for around 60% of diagnosed cases and deaths from all malignant neoplasms in persons under 65 years in Scotland. Over the 10 years from 1981 to 1990 the incidence rates of some other cancers not examined in this paper have risen significantly. Malignant melanoma, non-Hodgkin's lymphoma and testicular cancer have shown the greatest increases in incidence (Miller et al., 1993) . Under such circumstances age -period -cohort models are likely to describe the underlying trends more accurately than cross-sectional data.
The estimates of the age, period and birth cohort effects generated by the model are subject to errors which are, of course, proportionately greatest for less frequent cancers. Therefore, the site-specific estimates of percentage change in incidence will be more robust statistically than those for mortality. Also, the projections for the most common cancers (e.g. male lung cancer, female breast cancer) are more reliable than those for other sites. (Warner et al., 1993) . Although the long-term aim of the screening programme is to reduce mortality by 25% in the screened age group by the year 2000, in the short term incidence should rise. The magnitude of this rise is difficult to quantify and has not been incorporated in the statistical model. Therefore, it is likely that the incidence model will over-estimate to some extent the number of new cases of breast cancer in 2000. However, since the SBSP achieved national coverage in 1991, the mortality model describes the trends likely to occur in the absence of systematic screening. Thus, the prediction of a decrease of 21 % in the number of deaths due to cancer of the breast in women under 65 between 1986 and 2000 may under-estimate the actual reduction achieved should screening prove effective. The combined effect of long-term trends in mortality and the introduction of national breast screening cannot be quantified as it is, as yet, too early to formally evaluate the screening programme.
Cytological screening for cervical cancer, aimed at detecting lesions in the preclinical phase, has been offered on a systematic basis in some parts of Scotland for more than 30 years (Macgregor et al., 1994) . Screening policies have varied across the country and over time. Consequently, the effects of cervical screening on the statistical models for both incidence and mortality are likely to be complex and cannot be adequately assessed.
Trends in cancer risk factors For many of the cancers diagnosed in Scotland the risk factors are well understood. Muir (1993) estimates that at least one-third of all tumours in males and 17% in females are probably caused by smoking and a further 6% and 3% caused by the combined effects of tobacco and alcohol. As tobacco consumption, in particular, is implicated in the aetiology of many of the cancers common in Scotland, past and current patterns of tobacco use in the population will dictate a large part of future cancer incidence and mortality trends. From 1960 to 1980 the incidence of cancer of the lung rose steadily in Scottish men; since that time both incidence and mortality rates have been declining. For women a consistent upward trend was still apparent into the 1990s (ISD, 1994) . These data reflect the very strong birth cohort effect in lung cancer (Black et al., 1995) related to patterns of smoking behaviour in successive generations. For men the peak incidence occurred when the birth cohorts and age groups of highest risk coincided at the end of the 1970s. As smoking became prevalent among women some years later than in men, it is predicted that incidence will not peak until around 2000. Data on tobacco use in Scotland (ISD, 1994) reveal that the decline in smoking prevalence in women, notably younger women, has been less pronounced than in men. This may mean that the future decreases in lung cancer incidence and mortality in younger women will not be of the magnitude forecast in this paper.
The proportions of neoplasms in the Scottish population likely to be caused by aspects of lifestyle, including diet and reproductive factors, have been estimated to be 32% in males and 61% in females (Muir, 1993) . Diet now appears to be important in the genesis of several common cancers, although the contribution of diet to total cancer incidence and mortality cannot be quantified on the basis of present knowledge (WHO, 1990) . The Scottish diet is typically low in fruit, vegetable and fibre consumption and high in saturated fat, refined sugar and salt intake (SHHD, 1993) . Given that dietary patterns are often established at a very early age, it is likely that efforts to improve diet will be slow to take effect.
The frequencies of cancers of the breast, ovary and endometrium are influenced by past trends in reproductive factors in the population, particularly those associated with ovarian activity. Increased risk of breast cancer is established in relation to early age at menarche, late menopause, late age at first full-term pregnancy and low parity. The last of these is also an important risk factor for ovarian and endometrial cancer (Higginson et al., 1992) . Exogenous hormones also have a role in the aetiology of female cancers. While there is conclusive evidence that use of combined oral contraceptives protects against tumours of the uterus and ovary (Tomatis, 1990) , studies have suggested that their use in adolescent women may result in a slight increase in risk of breast cancer (UK National CaseControl Study Group, 1989; Peto, 1989 in Scotland are expected for males and females respectively (Registrar General, 1993 ) with even greater growth will be greatest in the numbers of very elderly. The population aged 85 and older is forecast to double. Cancer is likely to become a public health concern of increasing dimensions in this age group.
Complementary nature of incidence and mortality data. Several authors have reviewed the relative value of cancer incidence and mortality data (e.g. Barker, 1984; Boyle, 1989) . The routine availability of mortality data over many years has meant that mortality rates have become the most commonly used indicator of trends in cancer in human populations. However, mortality rates are the product of trends in both incidence of, and survival from, cancer. Hole, 1992) . However, since five year survival for malignant melanoma for patients diagnosed in the mid-1980s exceeded 70% , it is likely to be some time before mortality is affected. Similarly, the reduction in mortality from cancer of the breast following the introduction of mammographic screening in Sweden took several years to become apparent (Tabar et al., 1985) . Improved diagnostic techniques may also result in earlier diagnosis but such advances are difficult to anticipate.
The introduction of effective therapy is the route most likely to produce immediate and substantial reductions in mortality from cancer. For example, in the mid-1970s when combination chemotherapy utilising cisplatin was introduced for the treatment of testicular cancer, mortality fell sharply (Boyle et al., 1987) . To date however, increased survival as a direct result of advances in treatment has only been solidly established for testicular tumours, some childhood and young adult cancers (Birch et al., 1988; Hawkins, 1989 ) and Hodgkin's disease (Boyle et al., 1988) . Further developments in treatment for the more common cancers are difficult to predict. However, survival and, by extension, mortality may also be influenced by the organisation and availability of cancer diagnosis and treatment facilities. Studies have suggested that patients treated at specialist centres or teaching hospitals may have improved prognosis (Stiller, 1994; Harding et al., 1993; Gillis et al., 1991; Karjalainen, 1990) . The use of treatment protocols, both within and outwith clinical trials (Karjalainen and Palva, 1989 ) and treatment by a specialist (Junor et al., 1994; McArdle and Hole, 1991) have been shown to increase survival. Increasing the proportion of patients offered the best available therapy is likely to generate improvements in survival and, ultimately, mortality rates. Such factors have begun to be addressed in Scotland by the establishment of the Scottish Cancer Therapy Network (Aitken et al., 1994 ).
Conclusion
The Scottish Cancer Target. established in 1991. proposed that a reduction of 1500 in mortalitv from cancer in the under-65s should be achieved betw-een 1986 and 2000. On the basis of this analysis that target will be met. Mortality from cancer in those under 65 y-ears of age between 1986 and 2000 in Scotland will fall bv 17%0 in men and 250o in women. In contrast. however. it is projected that the number of newcancers diagnosed in this age group over the same time period will decrease by 60o in men but remain constant in women. W`e regret that the cancer tarzet published for Scotland addresses only one aspect of cancer control. namelv mortalitv. Without examination of the interplay between incidence and mortality it is impossible to obtain a sound understanding of the situation. Cancer control demands such an integrated approach.
